Cardinal Health, Inc. $CAH Position Cut by Savant Capital LLC

Savant Capital LLC trimmed its stake in Cardinal Health, Inc. (NYSE:CAH) by 62.6% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 13,103 shares of the company’s stock after selling 21,938 shares during the quarter. Savant Capital LLC’s holdings in Cardinal Health were worth $2,693,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. EagleClaw Capital Managment LLC bought a new stake in Cardinal Health in the fourth quarter valued at $236,000. Foundations Investment Advisors LLC bought a new stake in Cardinal Health in the fourth quarter valued at $206,000. Baker Avenue Asset Management LP bought a new stake in Cardinal Health in the fourth quarter valued at $273,000. IFG Advisory LLC lifted its stake in Cardinal Health by 11.0% in the fourth quarter. IFG Advisory LLC now owns 2,377 shares of the company’s stock valued at $488,000 after buying an additional 235 shares during the last quarter. Finally, Huntington National Bank lifted its stake in Cardinal Health by 2.9% in the fourth quarter. Huntington National Bank now owns 11,058 shares of the company’s stock valued at $2,272,000 after buying an additional 312 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Stock Down 0.1%

Shares of NYSE CAH opened at $196.57 on Monday. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $233.60. The firm’s 50-day simple moving average is $203.52 and its 200 day simple moving average is $208.81. The stock has a market cap of $46.04 billion, a P/E ratio of 30.06, a P/E/G ratio of 1.17 and a beta of 0.52.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same period in the previous year, the business earned $2.35 earnings per share. The company’s revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts anticipate that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be given a $0.5158 dividend. This represents a $2.06 annualized dividend and a yield of 1.0%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 31.19%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on CAH shares. TD Cowen raised their target price on Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a research note on Friday, May 1st. Zacks Research upgraded shares of Cardinal Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 12th. Weiss Ratings cut shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday, May 19th. UBS Group set a $260.00 price objective on shares of Cardinal Health and gave the company a “buy” rating in a research note on Friday, February 6th. Finally, Robert W. Baird set a $248.00 price objective on shares of Cardinal Health in a research note on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average price target of $241.80.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.